Recent advances in degradable lactide-based shape-memory polymers.

Biodegradable polymers are versatile polymeric materials that have a high potential in biomedical applications avoiding subsequent surgeries to remove, for example, an implanted device. In the past decade, significant advances have been achieved with poly(lactide acid) (PLA)-based materials, as they can be equipped with an additional functionality, that is, a shape-memory effect (SME). Shape-memory polymers (SMPs) can switch their shape in a predefined manner upon application of a specific external stimulus. Accordingly, SMPs have a high potential for applications ranging from electronic engineering, textiles, aerospace, and energy to biomedical and drug delivery fields based on the perspectives of new capabilities arising with such materials in biomedicine. This study summarizes the progress in SMPs with a particular focus on PLA, illustrates the design of suitable homo- and copolymer structures as well as the link between the (co)polymer structure and switching functionality, and describes recent advantages in the implementation of novel switching phenomena into SMP technology.

Reversible bidirectional shape-memory polymers.

Free-standing copolymer network samples with two types of crystallizable domains are capable of a fully reversible bidirectional shape-memory effect. One set of crystallizable domains determines the shape-shifting geometry while the other provides the thermally controlled actuation capability.

One-way and reversible dual-shape effect of polymer networks based on polypentadecalactone segments.

A series of degradable polymer networks containing poly(ω-pentadecalactone) (PPD) switching segments showing a thermally-induced shape-memory effect were synthesized by co-condensation of PPD-macrotriols or -tetrols with an aliphatic diisocyanate. Thermal and mechanical properties at different temperatures were explored for polymer networks as a function of crosslink density by varying the polymer chain segment length or the netpoint functionality. All polymer networks exhibited excellent shape-memory properties with shape recovery rates Rr between 99% and 100% determined in the 5th cycle under stress-free conditions. Furthermore, the polymer networks were capable of a reversible dual-shape effect based on crystallization induced elongation (CIE) and melting-induced contraction (MIC) in cyclic, thermomechanical experiments under constant stress. In these tests, the polymer networks were capable of a shape-change of 130%. The associated temperatures at which CIE or MIC occurred (TCIE and TMIC) were shown to be a function of the applied stress. By an increase of stress of 1.6 MPa, TCIE could be increased by 10 K.

Amorphous phase-segregated copoly(ether)esterurethane thermoset networks with oligo(propylene glycol) and oligo[(rac-lactide)-co-glycolide] segments: synthesis and characterization.

Completely amorphous copoly(ether)ester networks based on oligo(propylene glycol) and oligo[(rac-dilactide)-co-glycolide] segments were synthesized by crosslinking star-shaped hydroxyl-telechelic cooligomers using an aliphatic low-molecular weight diisocyanate. Two different network architectures were applied exhibiting differences in the phase-separation behavior. For networks from oligo(propylene glycol)-block-oligo[(rac-lactide)-co-glycolide] triols (G(3)OPG-bl-OLG) only one glass transition was obtained. However, networks from a mixture of oligo(propylene glycol) triols (G(3)OPG) and oligo[(rac-lactide)-co-glycolide] tetrols (P(4)OLG) with a ratio of components in a certain range show two glass transition temperatures (T (g)) being attributed to two segregated amorphous phases. In this way a wide spectrum of mechanical properties can be realized and adjusted to the requirements of a specific application.

Controlling the switching temperature of biodegradable, amorphous, shape-memory poly(rac-lactide)urethane networks by incorporation of different comonomers.

Biodegradable shape-memory polymers have attracted tremendous interest as potential implant materials for minimally invasive surgery. Here, the precise control of the material's functions, for example, the switching temperature T(sw), is a particular challenge. T(sw) should be either between room and body temperature for automatically inducing the shape change upon implantation or slightly above body temperature for on demand activation. We explored whether T(sw) of amorphous polymer networks from star-shaped rac-dilactide-based macrotetrols and a diisocyanate can be controlled systematically by incorporation of p-dioxanone, diglycolide, or epsilon-caprolactone as comonomer. Thermomechanical experiments resulted that T(sw) could be adjusted between 14 and 56 degrees C by selection of comonomer type and ratio without affecting the advantageous elastic properties of the polymer networks. Furthermore, the hydrolytic degradation rate could be varied in a wide range by the content of easily hydrolyzable ester bonds, the material's hydrophilicity, and its molecular mobility.

SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity.

Tyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the hydrolysis of the tyrosyl-3' phosphate linkage found in topoisomerase I-DNA covalent complexes. The inherited disorder, spinocerebellar ataxia with axonal neuropathy (SCAN1), is caused by a H493R mutation in Tdp1. Contrary to earlier proposals that this disease results from a loss-of-function mutation, we show here that this mutation reduces enzyme activity approximately 25-fold and importantly causes the accumulation of the Tdp1-DNA covalent reaction intermediate. Thus, the attempted repair of topoisomerase I-DNA complexes by Tdp1 unexpectedly generates a new protein-DNA complex with an apparent half-life of approximately 13 min that, in addition to the unrepaired topoisomerase I-DNA complex, may interfere with transcription and replication in human cells and contribute to the SCAN1 phenotype. The analysis of Tdp1 mutant cell lines derived from SCAN1 patients reveals that they are hypersensitive to the topoisomerase I-specific anticancer drug camptothecin (CPT), implicating Tdp1 in the repair of CPT-induced topoisomerase I damage in human cells. This finding suggests that inhibitors of Tdp1 could act synergistically with CPT in anticancer therapy.